Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Pott

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
The American Journal of Surgical Pathology|June 3, 2015
Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg TypeUlrike Wehkamp, Christiane Pott, Michael Unterhalt, et al.
Plos One|June 10, 2015
High-Throughput, Amplicon-Based Sequencing of the CREBBP Gene as a Tool to Develop a Universal Platform-Independent AssayMarc W Fuellgrabe, Dietrich Herrmann, Henrik Knecht, et al.
Pharmacogenetics and Genomics|August 31, 2010
A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimensHeike Horn, Christiane Pott, Jörg Kalla, et al.
Experimental Hematology & Oncology|October 1, 2020
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistanceTheresa Klümper, Henrike Bruckmueller, Tobias Diewock, et al.
Journal of Immunological Methods|September 27, 2005
Flow cytometric assay for determination of FcgammaRIIIA-158 V/F polymorphismSebastian Böttcher, Matthias Ritgen, Monika Brüggemann, et al.
Intensive Care Medicine|August 22, 2024
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicitiesTorsten Schroeder, Tjark Martens, Lars Fransecky, et al.
Haematologica|January 19, 2007
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcomePeter Dreger, Michael Rieger, Bärbel Seyfarth, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR and ddPCRChristiane Pott, Monika Brüggemann, Matthias Ritgen, et al.
Leukemia & Lymphoma|July 13, 2014
Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Virginia Amador, Mary Callanan, et al.
European Journal of Haematology|March 22, 2005
Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual diseaseChristiane Pott, Carsten Schrader, Monika Brüggemann, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
The American Journal of Surgical Pathology|June 3, 2015
Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg TypeUlrike Wehkamp, Christiane Pott, Michael Unterhalt, et al.
Plos One|June 10, 2015
High-Throughput, Amplicon-Based Sequencing of the CREBBP Gene as a Tool to Develop a Universal Platform-Independent AssayMarc W Fuellgrabe, Dietrich Herrmann, Henrik Knecht, et al.
Pharmacogenetics and Genomics|August 31, 2010
A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimensHeike Horn, Christiane Pott, Jörg Kalla, et al.
Experimental Hematology & Oncology|October 1, 2020
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistanceTheresa Klümper, Henrike Bruckmueller, Tobias Diewock, et al.
Journal of Immunological Methods|September 27, 2005
Flow cytometric assay for determination of FcgammaRIIIA-158 V/F polymorphismSebastian Böttcher, Matthias Ritgen, Monika Brüggemann, et al.
Intensive Care Medicine|August 22, 2024
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicitiesTorsten Schroeder, Tjark Martens, Lars Fransecky, et al.
Haematologica|January 19, 2007
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcomePeter Dreger, Michael Rieger, Bärbel Seyfarth, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR and ddPCRChristiane Pott, Monika Brüggemann, Matthias Ritgen, et al.
Leukemia & Lymphoma|July 13, 2014
Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Virginia Amador, Mary Callanan, et al.
European Journal of Haematology|March 22, 2005
Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual diseaseChristiane Pott, Carsten Schrader, Monika Brüggemann, et al.
Pageof 12